Betty Soliven to Antibodies, Monoclonal
This is a "connection" page, showing publications Betty Soliven has written about Antibodies, Monoclonal.
Connection Strength
0.182
-
Myasthenia gravis induced by avelumab. Immunotherapy. 2019 10; 11(14):1181-1185.
Score: 0.108
-
CD19 as a therapeutic target in a spontaneous autoimmune polyneuropathy. Clin Exp Immunol. 2014 Feb; 175(2):181-91.
Score: 0.074